Pro-Dex Inc

Pro-Dex Inc(PDEX)股票分析

$63.440

+3.369 (+5.31%)收盘时

Loading chart…
最高
63.660
开盘
61.010
成交量加权均价
62.70
成交量
38.94K
市值
64.62M
最低
61.010
成交额
2.44M
企业价值/息税折旧摊销前利润(TTM)
12.25

Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. The Company has patented adoptive torque-limiting software and sealing solutions, which appeal to its customers, primarily medical device distributors. It also manufactures and sells rotary air motors to a range of industries. The Company’s medical device products utilize designs developed by it primarily under development and supply agreements and are machined in its Irvine, California facility, and assembled in its Tustin, California facility, as are its rotary air motors. Its medical device products are sold primarily to original equipment manufacturers and its air motors are sold primarily to a range of distributors and end users. It manufactures machined sub-assemblies and also produces parts and assemblies for aerospace and defense systems.

AI 分析 of Pro-Dex Inc (PDEX)

持有

Currently, Pro-Dex Inc (PDEX) is trading at $57.65, which is significantly below its 52-week high of $77.00, indicating potential for recovery. However, the RSI is at 29.815, suggesting it is in oversold territory, which could lead to a rebound. The forward P/E ratio is 19.12, indicating that the stock may be overvalued based on future earnings expectations. The company reported a net income of $13.66 million for FY 2026, a 52% increase from the previous year, which is a positive sign for long-term investors. However, the stock has seen a 4.96% decline over the past five days, which reflects short-term volatility. Given these factors, it may be prudent to hold rather than buy at this moment, as the stock could stabilize before making a more informed investment decision.

分析师评级(1)

买入
1 买入
0 持有
0 卖出
当前: 63.44
最低
—
平均
—
最高
—

Ascendiant Capital

2024-11-11

目标价

$52

强烈买入

Ascendiant Capital

2024-09-09

目标价

$30

强烈买入

估值指标

Pro-Dex Inc(PDEX)当前预期市盈率为 18.66,5 年平均预期市盈率为 17.42。

预期市盈率

合理
5 年均值 P/E
17.42
当前P/E
18.66
高估
23.31
低估
11.53

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
10.48
当前EV/EBITDA
12.25
高估
13.50
低估
7.45

预期市销率

高估
5 年均值 P/S
1.70
当前P/S
2.22
高估
2.19
低估
1.20

Alphio AI 对 PDEX 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%PDEX

$55.23

情景价格

基

基准

基准 · 50%PDEX

$51.89

情景价格

悲

悲观

悲观 · 25%PDEX

$51.20

情景价格

PDEX 常见问题 —— 由 Alphio AI 解答

Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. The Company has patented adoptive torque-limiting software and sealing solutions, which appeal to its customers, primarily medical device distributors. It also manufactures and sells rotary air motors to a range of industries. The Company’s medical device products utilize designs developed by it primarily under development and supply agreements and are machined in its Irvine, California facility, and assembled in its Tustin, California facility, as are its rotary air motors. Its medical device products are sold primarily to original equipment manufacturers and its air motors are sold primarily to a range of distributors and end users. It manufactures machined sub-assemblies and also produces parts and assemblies for aerospace and defense systems. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Currently, Pro-Dex Inc (PDEX) is trading at $57.65, which is significantly below its 52-week high of $77.00, indicating potential for recovery. However, the RSI is at 29.815, suggesting it is in oversold territory, which could lead to a rebound. The forward P/E ratio is 19.12, indicating that the stock may be overvalued based on future earnings expectations. The company reported a net income of $13.66 million for FY 2026, a 52% increase from the previous year, which is a positive sign for long-term investors. However, the stock has seen a 4.96% decline over the past five days, which reflects short-term volatility. Given these factors, it may be prudent to hold rather than buy at this moment, as the stock could stabilize before making a more informed investment decision.

1 analysts cover PDEX: 1 rate it Buy, 0 Hold and 0 Sell.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易